Board Performance · 2024
In this section15 topics
- Compliance Monitoring — Overview1 item
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives5 items
- Selection of Independent Directors2 items
- Director Development1 item
- Evaluation of Board & Subcommittee Performance2 items
- Subcommittees1 item
- Meeting Attendance & Remuneration3 items
- Supervision of Subsidiaries & Associated Companies5 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Compliance Monitoring — Overview
Monitoring of Compliance with Other CG Policies & Guidelines
-
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
To prevent conflicts of interest, the Company has established clear policies for managing transactions that may give rise to conflicts of interest. The Company has established written procedures for approving connected transactions between the Company or individuals who may have a conflict of interest. In the event that a director has an interest in any agenda, that director shall not be entitled to vote on such agenda.
In addition, the Company has established guidelines to prevent conflicts of interest between the Company, its subsidiaries, associates, and related companies as follows:
(1) The location of the Company and its associates or related companies engaged in the same healthcare business must be at least 10 kilometers apart (for newly built hospitals).
(2) For hospitals that are already in operation and located less than 10 kilometers apart, the Company cannot rectify the location issue. However, the Company will have a management policy that does not involve competing for customers. There will be a division of customers based on area and the financial status of patients in overlapping areas. The Company may also consider providing mutual medical treatment assistance.
(3) The Company has established guidelines for sending representatives to serve on the Board of Directors and as executives in subsidiaries, associates, and related companies as follows:
(3.1) For subsidiaries: The Company will send directors to serve on the Board of Directors and as executives to establish management policies, operations, financial reporting, and to supervise and oversee the subsidiaries' activities in accordance with good corporate governance policies.
(3.2) For associates: The Company will send representatives to serve on the Board of Directors as shareholders of the associate, in proportion to their shareholding, and participate in approving the agenda presented to the Board of Directors of the associate in accordance with normal business operations. If there is any agenda in which the Company has an interest (connected transaction), the Company's representative will abstain from voting on such agenda. The Company has considered the appropriateness of investing in any associate, both in terms of strengthening the business and the return on investment through dividends that the Company will receive, which must result from the associate's good operating results, improved cost control, and consistent dividend payments to shareholders. Therefore, the Company may consider sending representatives to serve as executives of the associate in cases where the Company sees an opportunity to improve the associate's operating results through the exchange of knowledge, expertise, or assistance in improving cost management, such as joint procurement of medical equipment and instruments to increase bargaining power in terms of price and receive better after-sales service. However, if any associate has stable and good growth performance, the Company may only send representatives to serve as directors.
(3.3) For related companies: As the Company holds a minority stake, it will not send representatives to serve on the Board of Directors or as executives, except in cases where the related company requests the Company to send representatives to serve on the Board of Directors or as executives to exchange knowledge, expertise, or assist in improving the cost management of the related company, which is to maximize the benefits of investing in such businesses. However, if there is any agenda in which the Company has an interest (connected transaction), the representative who is a director of the company will abstain from voting on such agenda.
(4) The Company's Board of Directors has established policies and procedures to prevent executives and related parties from using the Company's, its subsidiaries', or other companies' inside information for personal gain or conflicts of interest. These policies are stipulated in the Code of Business Conduct and the Company's Code of Conduct, which have been published on the Company's website as follows:
“The Board of Directors, subcommittees, executives, and employees of the Company and its subsidiaries who have interests or potential conflicts of interest, both directly and indirectly, with the Company or its subsidiaries, including holding positions in other companies with the same business as the Company, shall not disclose or use any confidential information of the Company or its subsidiaries to other companies and/or any other person in a manner that may cause a conflict of interest with the Company or its subsidiaries, such as financial information that has not yet been disclosed to the public, except for the disclosure of information to enable that company to use such information to comply with rules, announcements, regulations, or requirements regarding the disclosure of information reports of relevant agencies.”
In approving intercompany transactions, the responsible unit, in conjunction with the Risk Management and Investment Committee, will initially assess such transactions. They will gather information and analyze whether the transactions are reasonable, in the best interests of the Company, and at a fair price. The transactions will then be presented according to the approval procedures and processes. Executives or directors with conflicts of interest will not be involved in the approval of such transactions.
In 2024, the Company did not find any conflicts of interest between the Board of Directors, executives, and employees of the Company that could lead to conflicts of interest.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The Company has policies and procedures in place to prevent directors and executives from using the Company's inside information for personal gain. These policies require directors and senior executives to report changes in their shareholdings to the Securities and Exchange Commission (SEC) in accordance with Section 59 of the Securities and Exchange Act of 1992, as well as to notify the Company Secretary of such changes.
In addition, the Company has a securities trading policy that prohibits directors, senior executives, and related persons who possess inside information from buying or selling securities or entering into futures contracts related to securities, whether for themselves or others, 15 days prior to the public disclosure of quarterly and annual financial statements.
The Board of Directors' Meeting No. 1/2024, held on January 30, 2024, acknowledged the blackout period for securities trading in 2024, as stipulated in the policy on securities trading by directors, executives, and related persons.
In 2024, there were no incidents of directors, executives, employees, or related persons violating the Company's insider trading prevention measures or engaging in insider trading for personal gain.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The Company conducts its business with a commitment to combating all forms of fraud. We have established a fraud risk assessment, risk management, and monitoring process to prevent and suppress fraud and misconduct. We also strive to foster a corporate culture that upholds integrity and righteousness. The Company has formulated an anti-fraud policy and guidelines, which have been communicated to the Company's executives and employees and published on the Company's website.
Corruption means any act of offering, promising, soliciting, demanding, giving, or accepting assets or other benefits to or from a state official or any other person conducting business with the Company, whether directly or indirectly, in order for such person to perform or refrain from performing their duties to obtain or maintain any business advantage, except as permitted by law, regulations, rules, local customs, or business practices.
Directors, executives, and employees shall not engage in or tolerate any form of corruption under any circumstances. The Company has established guidelines for the regular review and revision of its anti-corruption policy to ensure its consistency with changes in business, regulations, rules, and relevant laws.
Code of Conduct
1. Directors, executives, and employees must comply with the anti-corruption policy that the Company has communicated and disseminated through various channels, such as employee training and the Company's website, and must not engage in corruption, both directly and indirectly.
2. Directors, executives, and employees must be cautious about accepting or providing entertainment, as well as giving or receiving gifts. They must strictly comply with the policy on giving or receiving gifts or other benefits and ensure that it does not affect their decision-making in the performance of their duties.
3. Procurement, charitable donations, and financial support must be in accordance with the Company's transparent and auditable regulations and procedures. The Company's policy on charitable donations and financial support must be followed. The Company places importance on adequate and appropriate internal control to ensure that operations are in line with good governance principles.
4. Directors, executives, and employees should not ignore or overlook any acts that may be considered corruption related to the Company. They must notify their supervisor, the person in charge, or through the channels specified in the Company's whistleblowing and complaint policy, and cooperate in the investigation of facts.
5. Those who commit corruption are guilty of an offense and are subject to disciplinary action under the Company's regulations and may be subject to legal penalties if the act is a violation of the law.
Form of Anti-Corruption Operations
| Operation |
|---|
| Review of appropriateness in anti-corruption |
| Communication and training for employees on anti-corruption policy and guidelines |
| Review of the completeness and adequacy of the process by the Audit Committee or auditor |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
Yes
Operations in the Past Year
Whistleblowing
The Board of Directors provides an opportunity for directors, executives, employees, and stakeholders both inside and outside the Company and its subsidiaries to report wrongdoing, complaints, or suggestions regarding legal violations, business ethics, inaccurate financial reporting, corruption, or deficiencies in the internal control system of the Company and its subsidiaries. The Company will investigate these whistleblowing reports, complaints, or suggestions to determine the facts and establish control measures. This can be done through the following channels:
By E-mail secretary@ram-hosp.co.th
Company website https://www.ram-hosp.co.th/
By mail, submit a whistleblowing and complaint form
To the Board of Directors, Chairman of the Audit Committee, Head of Internal Audit
Ramkhamhaeng Hospital Public Company Limited
436 Ramkhamhaeng Road, Hua Mak Subdistrict, Bang Kapi District, Bangkok 10240
Complaint handling process
Initially, the Internal Audit Department is responsible for overseeing, collecting, filtering information, investigating facts, and summarizing complaints to the Hospital Director. The Hospital Director will appoint an investigating committee to filter information and conduct an investigation. Representatives of the investigating committee participating in the consideration include the Human Resources Director or a representative from the department, the supervisor in the complainant's line of work who must be a person with no conflict of interest with the complainant, a representative from the Risk Management Working Group, the Secretary of the Audit Committee, or a representative from the Audit Committee to observe.
After the investigation, the Internal Audit Department will summarize the report and submit the report on the progress of the complaint and whistleblowing to the Audit Committee. In the case of matters that affect the reputation, image, or financial status of the Company, or matters that conflict with the Company's business policies, or matters related to senior management, the Audit Committee will propose to the Board of Directors for further consideration.
Measures to protect whistleblowers and complainants, including confidentiality
The Board of Directors has established policies and guidelines to protect whistleblowers and complainants. The information of whistleblowers and complainants will be kept confidential. Those who receive information from performing duties related to the matter are obliged to keep the information, complaints, and supporting documents of whistleblowers and complainants confidential and must not disclose the information to unrelated persons, except for disclosures required by law.
In 2023, the Company did not encounter any complaints regarding corruption and there were no cases of violation of the business ethics.
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
7
Rights of Minority Shareholders on Director Appointment
-
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Criteria for Selecting Independent Directors
The criteria for the recruitment of independent directors, in addition to the criteria for the recruitment of directors, are as follows:
The Nomination and Remuneration Committee shall consider the independence of independent directors, who must possess qualifications in accordance with the regulations related to the provisions on independent directors, consistent with the Company's qualifications for independent directors, and be able to express opinions independently and present them to the Board of Directors (excluding interested directors) for approval before submitting them to the shareholders' meeting for further consideration.
Did Any Independent Director Have a Business or Professional Relationship?
No
Director Development
Qualifications for Director Selection
| Qualification | Skill & Expertise |
|---|---|
| The Board of Directors comprises individuals with diverse knowledge, capabilities, and expertise, encompassing skills, experience, and specialized abilities beneficial to the Company's current business operations. The Company has a Board structure that embraces diversity (Board Diversity), aligning with its business operations, with a total of 15 members. | 134 · Description: Health Care Services · 141 · Description: Law · 143 · Description: Accounting · 144 · Description: Finance · 1683 · Description: Business Administration |
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
The assessment of the overall performance of the Board of Directors and sub-committees (As a Whole) and individual self-assessments (Self-Assessment) to comply with the principles of good corporate governance for listed companies and to jointly consider the overall performance, including improvements to the duties and responsibilities of the Board of Directors to benefit the company with maximum efficiency and effectiveness.
Evaluation of Board Performance in the Past Year
The evaluation of the performance appraisal of individual directors consists of 3 topics: (1) Structure and Qualifications (2) Meetings (3) Duties and Responsibilities. The evaluation found that the performance of individual directors is “very good”.
The performance evaluation of the Board of Directors and sub-committees consists of 4 topics: (1) Structure and Qualifications (2) Meetings (3) Duties and Responsibilities, and (4) Others. The evaluation found that the performance of the Board of Directors is “very good”, with the following details:
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance |
|---|
In 2024, the Risk Management and Investment Committee held 3 meetings to perform its duties in accordance with the Risk Management and Investment Committee Charter, which summarizes the key points of its duties as follows: 1. Risk Management 1.1 Consider the risk management plan of various investment structures to provide recommendations to the Board of Directors for further consideration. 1.2 Oversee enterprise-wide risk management, covering operational, financial, business, operational, administrative and organizational, occupational health and safety and environmental risks, and other significant risks related to the Company's business. 2. Investment 2.1 Consider and approve the investment policy in debt instruments and equities of the Group. 2.2 Consider and approve investments in various important projects to provide recommendations to the Board of Directors for further consideration. The Risk Management and Investment Committee has performed its duties in accordance with the charter and as assigned by the Board of Directors to ensure that all stakeholders receive maximum and equal benefits. |
In 2024, the Nomination and Remuneration Committee convened twice to perform its duties as stipulated in the Nomination and Remuneration Committee Charter. The key aspects of its responsibilities are as follows: 1. Conducting the recruitment and selection of qualified and suitable individuals to serve as the Company's directors in accordance with the established processes and criteria, for the purpose of proposing their appointment for approval by the Board of Directors or the Shareholders' Meeting (as the case may be). The qualifications considered encompass education, expertise, skills, experience, and specific capabilities relevant to the Company's business. 2. Considering and determining the annual remuneration for the Company's directors for 2024, to be proposed for approval in accordance with the established procedures. This process takes into account the appropriateness of the remuneration in comparison to the directors' performance, responsibilities, and the overall performance of the Company. Benchmarking data on director remuneration from leading listed companies, as well as the overall business environment, are also considered. 3. Proposing criteria for the performance evaluation of the Board of Directors to the Board of Directors, to be used in assessing the overall performance of the various Board committees. |
Meeting Attendance & Remuneration
Justification for Directors' Non-Attendance
Busy with other tasks
Types of Remuneration of the Board of Directors
Monetary compensation, without other benefits.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
Yes
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
Yes
Mechanism for Overseeing Management of Subsidiaries
The Board of Directors recognizes the importance of good corporate governance based on the principles of corporate governance. The focus is on conducting business with transparency, accountability, ethics, and compliance with relevant laws. The Board of Directors has assigned executives to serve on the boards of subsidiaries and associated companies as appropriate. The Board has also provided policies to directors working with subsidiaries and associated companies, especially by providing policies directly to the boards of directors of subsidiaries and associated companies on business risks. As the private hospital business is considered an important business that must care for patients according to medical ethics, the Board of Directors prioritizes having a system with quality standards, risks related to patient rights, risks in the operating system, and risks in other areas such as financial risk, financial reporting, accounting standards, and financial risk assessment that affect the business. The guidelines are similar to those of Ramkhamhaeng Hospital Public Company Limited, as follows:
1) Internal Reporting System: The Board of Directors has established meetings to report at the executive level to acknowledge business operations, system development, and problem-solving on a weekly basis, and to report operating results on a monthly basis.
2) External Reporting System: The Board of Directors has established a system for reporting quarterly and annual operating results in conjunction with the reports of the auditors.
3) Information Disclosure Policy: Financial position and operating results, related party transactions, asset acquisitions, or other material transactions will be reported by the Board of Directors in accordance with accounting standards, which have been audited by a certified auditor, as required by the Stock Exchange of Thailand.
4) The Board of Directors appoints directors and executives and defines the scope of duties and responsibilities of the persons acting as representatives to act honestly to protect the interests of the subsidiary and to comply with the Company's policies in accordance with good corporate governance principles and relevant laws. At the same time, the Company has established a policy for voting as a director of a subsidiary on important resolutions such as capital reductions, capital increases, balance sheet approvals, management structure approvals, or various transactions as required by the Securities and Exchange Act. These must be in accordance with the guidelines set by the Company, including the principles of good corporate governance established by the Company.
The Company does not have any agreements with other shareholders regarding the management of subsidiaries and associated companies, except for the investment in Thonburi Rangsit Company Limited, which has a shareholder agreement that has been notified to the Stock Exchange of Thailand.
Oversight Mechanisms
| Mechanism |
|---|
| Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings |
| Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies |
| Disclosure of financial information and operating results |
| Transactions between the Company and related persons |
Agreements Between the Company and Shareholders in Managing Subsidiaries
-
Board Duty Performance — Overview
Board Duty Performance — Overall Description
In 2024, the company will use the following criteria and director selection process:
Criteria
The Nomination and Remuneration Committee is responsible for considering, selecting, and nominating qualified individuals for directorship with transparency. The nominated individuals must possess knowledge, capability, and the ability to perform their duties with diligence, honesty, and full dedication. The committee also considers the list of individuals proposed by the shareholders for directorship (if any).
Recruitment
• From the list of individuals proposed by the shareholders for directorship (if any)
• From the recommendations of the Board of Directors
• From external consultants
Selection and Appointment Process
The Nomination and Remuneration Committee carefully considers and selects individuals who meet the specified criteria. The committee evaluates the specific expertise of the directors (Board Skill Matrix) to determine the qualifications of the directors to be recruited. This evaluation considers the necessary skills and alignment with the company's business strategies. The committee then proposes the candidates to the Board of Directors (excluding interested directors) for approval before submitting them to the shareholders' meeting for further consideration.
Reappointment
Various factors will be considered, such as past performance, meeting attendance, and participation in meetings.
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
In 2024, the Audit Committee held a total of 6 meetings to carry out its assigned responsibilities. The key issues were:
1. Review the financial statements of the Company and its subsidiaries before presenting them to the Board of Directors. Based on the review of the financial statements, inquiries of management, meetings with the auditors without management present, and consideration of the auditors' recommendations, the Audit Committee is of the opinion that the financial statements have been prepared fairly, completely, and reliably.
2. Review and assess the adequacy of the internal control system. The Audit Committee is of the opinion that the Company has an appropriate, effective, and adequate internal control system to mitigate risks arising from operations in accordance with the Company's policies and strategies.
3. Review the Company's compliance with the Securities and Exchange Act, the Stock Exchange's regulations, and laws related to the Company's business.
4. Consider, select, and propose the appointment of independent persons from Dhammaniti Audit Co., Ltd. as the Company's auditor and propose their remuneration.
5. Consider connected transactions or transactions that may involve conflicts of interest to ensure compliance with laws and regulations of the Stock Exchange. The Audit Committee is of the opinion that such transactions are in the ordinary course of the Company's business.
6. Consider approving the internal audit plan, which is designed to be consistent with the nature of the Company's business, including its policies, plans, work processes, and business risks.
7. Consider approving the annual budget and headcount for the Internal Audit Department.
8. Consider reviewing the Audit Committee Charter to ensure that it is appropriate for the regulations, requirements, and changing circumstances, and propose amendments to the Board of Directors for approval.
9. Consider reviewing the internal control system, financial reporting, and risk management system to be rigorous, appropriate, and effective, including inspecting and reviewing practices to ensure they are correct, in accordance with regulations and laws, to ensure that there is an adequate and sufficient control system for potential corruption risks.
10. Review the Company's and its subsidiaries' lending and investment policies to cover current conditions and investment patterns.
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
In 2023, the Executive Committee of the Group held a total of 29 meetings, considering and approving important matters before presenting them to the Board of Directors. The summary is as follows:
1. Review the business direction, policies, and strategies of the Company.
2. Review the business plan, annual budget, expenses, and investment plan.
3. Supervise the operations of the Company and its subsidiaries to comply with the established plans.
4. Approve or review the credit limit or lending limit between the Company and its subsidiaries.
5. Appoint working groups to solve and rectify various problems to align with the Company's policies.

